Warren Ribley Named President & CEO Of iBio, Inc. (IBIO) And The iBIO Institute

The Illinois Biotechnology Industry Organization—better known as iBIO®--and its affiliate, the iBIO® Institute--today announced that Warren Ribley has been named President & CEO of both organizations. He will assume his new responsibilities at the beginning of February 2015.

Appointed to lead the Illinois Medical District in April of 2012, Ribley is widely credited with revitalizing the District and attracting new tenants and life sciences developments, including the University of Illinois' Health Technology Innovation center (HTI).

Suggested Articles

Gilead Chief Scientific Officer and R&D chief John McHutchison, M.D., is leaving one year after he replaced R&D lead Norbert Bischofberger, Ph.D.

Astellas will develop Frequency's hearing loss drug outside the U.S. in exchange for $80 million upfront and the promise of $545 million down the line.

Inovio Pharmaceuticals is cutting 28% of its workforce and swinging the ax to a bladder cancer test.